Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Severe Microcephaly and Metabolic Epilepsy due to Asparagine Synthetase Deficiency. | Ann Indian Acad Neurol | 2023 | 37970270 | PubTator, text mining | PubMed |
| Transcultural adaptation and validation of the Serbian version of Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-Patient Satisfaction (FACIT-TS-PS) questionnaire. | PLoS One | 2023 | 37967091 | PubTator, text mining | PubMed |
| A method for measurement of human asparagine synthetase (ASNS) activity and application to ASNS protein variants associated with ASNS deficiency. | Biol Methods Protoc | 2023 | 37965492 | Swiss-Prot, curated | PubMed |
| Activation of the integrated stress response rewires cardiac metabolism in Barth syndrome. | Basic Res Cardiol | 2023 | 37930434 | PubTator, text mining | PubMed |
| A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition. | Malays J Med Sci | 2023 | 37928798 | PubTator, text mining | PubMed |
| Ferroptosis: the emerging player in remodeling triple-negative breast cancer. | Front Immunol | 2023 | 37928550 | PubTator, text mining | PubMed |
| Metabolic disturbance and transcriptomic changes induced by methyl triclosan in human hepatocyte L02 cells. | Toxicol Res (Camb) | 2023 | 37915488 | PubTator, text mining | PubMed |
| Genome-wide census of ATF4 binding sites and functional profiling of trait-associated genetic variants overlapping ATF4 binding motifs. | PLoS Genet | 2023 | 37906604 | PubTator, text mining | PubMed |
| Case report: A compound heterozygous mutations in ASNS broadens the spectrum of asparagine synthetase deficiency in the prenatal diagnosis. | Front Pediatr | 2023 | 37900678 | Swiss-Prot, curated | PubMed |
| Mechanistic Insights into the Anti-Proliferative Action of Gut Microbial Metabolites against Breast Adenocarcinoma Cells. | Int J Mol Sci | 2023 | 37894734 | PubTator, text mining | PubMed |
| A DNA/RNA heteroduplex oligonucleotide coupling asparagine depletion restricts FGFR2 fusion-driven intrahepatic cholangiocarcinoma. | Mol Ther Nucleic Acids | 2023 | 37869260 | PubTator, text mining | PubMed |
| Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition. | Cancer Metab | 2023 | 37858256 | PubTator, text mining | PubMed |
| Utility of ASNS gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL. | Epigenetics | 2023 | 37839090 | PubTator, text mining | PubMed |
| Role of Ubiquitination and Epigenetics in the Regulation of AhR Signaling in Carcinogenesis and Metastasis: "Albatross around the Neck" or "Blessing in Disguise". | Cells | 2023 | 37830596 | PubTator, text mining | PubMed |
| Glutamine metabolism in tumor metastasis: Genes, mechanisms and the therapeutic targets. | Heliyon | 2023 | 37829798 | PubTator, text mining | PubMed |
| Arginine reprograms metabolism in liver cancer via RBM39. | Cell | 2023 | 37804830 | PubTator, text mining | PubMed |
| Comparative study of the mechanism of natural compounds with similar structures using docking and transcriptome data for improving in silico herbal medicine experimentations. | Brief Bioinform | 2023 | 37798251 | PubTator, text mining | PubMed |
| A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM-STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma. | Adv Sci (Weinh) | 2023 | 37789644 | PubTator, text mining | PubMed |
| Genetic Aspects of Conjunctival Melanoma: A Review. | Genes (Basel) | 2023 | 37761808 | PubTator, text mining | PubMed |
| Unlocking the Potential: Amino Acids' Role in Predicting and Exploring Therapeutic Avenues for Type 2 Diabetes Mellitus. | Metabolites | 2023 | 37755297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=8